Table S1 from First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas

Authors :: Nancy L. Bartlett
Adrian Woolfson
Aron Thall
Kolette D. Fly
Bo Huang
Craig B. Davis
Ying Chen
Keith A. Ching
Shibing Deng
Xinmeng J. Mu
Caron Jacobson
Leslie Popplewell
Sandip P. Patel
Roch Houot
Ronald Levy
Ajay K. Gopal
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Select laboratory abnormalities by maximum CTCAE grade

Full Text Access

Tools